BOVILIS Guardian (Canada)

Bovine Rotavirus-Coronavirus Vaccine, Killed Virus, Clostridium Perfringens Type C & D-Escherichia Coli Bacterin-Toxoid

Cattle Vaccine

Bovilis^® Guardian™ vaccine is a multiple antigen product which includes a cell-free extract of K99 pilus type of Escherichia coli, a unique combination of two inactivated coronaviruses, two G-types of inactivated rotaviruses and a bacterin-toxoid from Clostridium perfringens Types C and D. It is recommended for use in healthy pregnant heifers and cows as an aid in the prevention of neonatal calf diarrhea caused by bovine Group A Serotype G6 rotaviruses, enterotoxigenic E. coli pilus type K99, and enterotoxemia caused by C. perfringens Types C & D, and as an aid in the control of neonatal calf diarrhea caused by bovine coronavirus.

DOSAGE: Using aseptic technique, inject healthy pregnant cattle with 2 mL subcutaneously 3 months prior to calving. Repeat in 3 - 6 weeks following initial vaccination. For subsequent calvings, revaccinate with a single 2 mL dose 5 - 7 weeks before calving. For E. Coli, protection was shown when the first dose was given as early as six months prior to calving.

BOVILIS Guardian Caution

Store at 2° to 7°C (35° to 45°F). Do not freeze. Shake well before use. Use entire contents when first opened. Do not vaccinate within 60 days prior to slaughter. Transient local reaction may occur at the injection site. If allergic response occurs, administer epinephrine.

PRESERVATIVES: Gentamicin and thimerosal. FOR ANIMAL USE ONLY.

Intervet Inc. d/b/a Merck Animal Health, Omaha, NE 68103, USA

VLN 165A/PCN 4575.20

1 800 521-5767 (USA)

1 866 683-7838 (CAN)

For Patent info.:

http://www.merck.com/product/patent/home.html

CPN: 1208297.0